Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Artificial Intelligence Technology Solutions ( (AITX) ) has provided an announcement.
On May 19, 2025, AITX announced a nationwide demonstration tour for its ROAMEO Gen 4 security robot, set to begin in June. The tour aims to showcase ROAMEO’s advanced autonomous patrol capabilities across major industries, following RAD’s receipt of the 2024 Enabling Technology Leadership Award from Frost & Sullivan. The tour will include demonstrations at prominent locations such as large retailers, healthcare networks, and logistics hubs, highlighting ROAMEO’s potential to modernize security operations and reduce costs. Initial deployments of ROAMEO units are expected in August and September, with the tour anticipated to boost demand and accelerate sales.
Spark’s Take on AITX Stock
According to Spark, TipRanks’ AI Analyst, AITX is a Underperform.
The overall stock score reflects significant financial challenges, including high leverage and liquidity issues, combined with negative profitability. The lack of technical and valuation appeal further weighs down the score, leading to the lowest possible rating on the scale.
To see Spark’s full report on AITX stock, click here.
More about Artificial Intelligence Technology Solutions
Artificial Intelligence Technology Solutions, Inc. (AITX) is a leader in the delivery of AI-based solutions, focusing on enhancing security and guarding services through its subsidiary, Robotic Assistance Devices, Inc. (RAD). The company offers a range of robotic solutions designed to significantly reduce costs and improve efficiency in industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare.
Technical Sentiment Signal: Sell
Current Market Cap: $20.54M
For a thorough assessment of AITX stock, go to TipRanks’ Stock Analysis page.